FindMyKOL

Donald Bodenner, MD

Basic profile

University of Arkansas for Medical Sciences

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionLittle Rock, AR · South CentralSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLFindMyKOL type: RegionalLatest publication2018Online presenceNot yet checkedPayments2021 onwardNIH funding1997–2006Why? →

Donald Bodenner is an Endocrinology/Metabolic physician affiliated with University of Arkansas for Medical Sciences. OpenAlex indexes 93 publications with 4,058 citations (h-index 30); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
93publications

Publications indexed by OpenAlex. Counts exclude supporting files.

4,058citations

Citations across these publications.

30h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
3companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
2NIH grants · 1997–2006

Federally funded research awards.

View funding ↓

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Caris MPI, Inc.
    Program year20251 payment
    $17
  • Lilly USA, LLC
    Program year20231 payment
    $125
  • Eisai Inc.
    Program year20211 payment
    $1,110

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Hormonal (systemic)

    43.8%
    l-Thyroxine32.3%
    Levothyroxine Sodium82%Synthroid18%
    Part D≥86 patients
    Thyroid Hormone Synthesis Inhibitor10.2%
    Methimazole100%
    Part D≥23 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    32.6%
    Biguanide (metformin)7.3%
    Metformin Hcl75%Metformin Hcl Er25%
    Part D<11 patients
    Insulin Analog6.8%
    Lantus Solostar40%Toujeo Solostar22%Basaglar Kwikpen U-10019%Levemir Flexpen19%
    Part D<11 patients

    + 8 more classes in this area

  • Cardiovascular

    12.9%
    Statin6.3%
    Atorvastatin Calcium64%Pravastatin Sodium36%
    Part D<11 patients
    Calcium channel blocker2.6%
    Amlodipine Besylate100%
    Part D<11 patients

    + 2 more classes in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

2 NIH research awards on record, funded 1997–2006 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”